Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Express Scripts
Moodys
McKinsey
Colorcon

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,962,151

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,962,151
Title: Inhalation nebulizer
Abstract:An inhalation nebulizer (1) includes an aerosol generator (2) that has a diaphragm (22) vibrated by a vibration generator (23). The inhalation nebulizer (1) includes a liquid storage container (21) that is in fluid contact with the diaphragm (22). A liquid contained in the storage container (21) is atomized into a mixing chamber (3) through openings in the diaphragm and can subsequently be inhaled by a patient.
Inventor(s): Knoch; Martin (Berg, DE), Keller; Manfred (Bad Krozingen, DE), Stangl; Roland (Moosburg, DE), Gallem; Thomas (Munich, DE), Liening-Ewert; Rainer (Alfausen, DE), Urich; Markus (Munich, DE)
Assignee: Pari GmbH Spezialisten fur effektive Inhalation (Starnberg, DE)
Application Number:10/129,498
Patent Claim Types:
see list of patent claims
Use; Formulation; Delivery; Device; Dosage form;

Drugs Protected by US Patent 6,962,151

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,962,151

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany199 53 317Nov 5, 1999
PCT Information
PCT FiledOctober 27, 2000PCT Application Number:PCT/US00/29541
PCT Publication Date:May 17, 2001PCT Publication Number: WO01/34232

International Family Members for US Patent 6,962,151

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 404234   Start Trial
Australia 1234801   Start Trial
Australia 1698301   Start Trial
Australia 781911   Start Trial
Canada 2389936   Start Trial
Germany 19953317   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Baxter
Merck
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.